Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of K-134 for intermittent claudication
jRCT2080221661Phase 2
- Sponsor
- Kowa Company, Ltd.
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intermittent claudication (IC) and arteriosclerosis obliterans comparing K-134 with Placebo (2 arms).
02
Drugs
K-134
03
Conditions
intermittent claudication (IC)arteriosclerosis obliterans
Beyond the preview
Go deeper on jRCT2080221661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221661.